126 related articles for article (PubMed ID: 29549749)
21. Basified Human Lysozyme: A Potent Inhibitor against Amyloid β-Protein Fibrillogenesis.
Li X; Xie B; Sun Y
Langmuir; 2018 Dec; 34(50):15569-15577. PubMed ID: 30407837
[TBL] [Abstract][Full Text] [Related]
22. Colloidal properties of biodegradable nanoparticles influence interaction with amyloid-β peptide.
Brambilla D; Souguir H; Nicolas J; Mackiewicz N; Verpillot R; Le Droumaguet B; Taverna M; Couvreur P; Andrieux K
J Biotechnol; 2011 Dec; 156(4):338-40. PubMed ID: 21807038
[TBL] [Abstract][Full Text] [Related]
23. Amyloid-β peptide (1-42) aggregation induced by copper ions under acidic conditions.
Bin Y; Li X; He Y; Chen S; Xiang J
Acta Biochim Biophys Sin (Shanghai); 2013 Jul; 45(7):570-7. PubMed ID: 23747389
[TBL] [Abstract][Full Text] [Related]
24. Injectable deferoxamine nanoparticles loaded chitosan-hyaluronic acid coacervate hydrogel for therapeutic angiogenesis.
S V; A S; Annapoorna M; R J; Subramania I; Shantikumar V N; R J
Colloids Surf B Biointerfaces; 2018 Jan; 161():129-138. PubMed ID: 29055865
[TBL] [Abstract][Full Text] [Related]
25. Mechanistic insights into the inhibition of amyloid-β aggregation by chitosan.
Gotla S; Matysiak S
Phys Chem Chem Phys; 2023 Apr; 25(14):10113-10120. PubMed ID: 36974715
[TBL] [Abstract][Full Text] [Related]
26. Effect of preparation parameters on ultra low molecular weight chitosan/hyaluronic acid nanoparticles.
Nazeri N; Avadi MR; Faramarzi MA; Safarian S; Tavoosidana G; Khoshayand MR; Amani A
Int J Biol Macromol; 2013 Nov; 62():642-6. PubMed ID: 24099942
[TBL] [Abstract][Full Text] [Related]
27. Biomolecular Corona Dictates Aβ Fibrillation Process.
Lotfabadi A; Hajipour MJ; Derakhshankhah H; Peirovi A; Saffar S; Shams E; Fatemi E; Barzegari E; Sarvari S; Moakedi F; Ferdousi M; Atyabi F; Saboury AA; Dinarvand R
ACS Chem Neurosci; 2018 Jul; 9(7):1725-1734. PubMed ID: 29676567
[TBL] [Abstract][Full Text] [Related]
28. Multifunctionality of Acidulated Serum Albumin on Inhibiting Zn²⁺-Mediated Amyloid β-Protein Fibrillogenesis and Cytotoxicity.
Xie B; Dong X; Wang Y; Sun Y
Langmuir; 2015 Jul; 31(26):7374-80. PubMed ID: 26070334
[TBL] [Abstract][Full Text] [Related]
29. Controlling amyloid-beta peptide(1-42) oligomerization and toxicity by fluorinated nanoparticles.
Saraiva AM; Cardoso I; Pereira MC; Coelho MA; Saraiva MJ; Möhwald H; Brezesinski G
Chembiochem; 2010 Sep; 11(13):1905-13. PubMed ID: 20661987
[TBL] [Abstract][Full Text] [Related]
30. Randomization of amyloid-β-peptide(1-42) conformation by sulfonated and sulfated nanoparticles reduces aggregation and cytotoxicity.
Saraiva AM; Cardoso I; Saraiva MJ; Tauer K; Pereira MC; Coelho MA; Möhwald H; Brezesinski G
Macromol Biosci; 2010 Oct; 10(10):1152-63. PubMed ID: 20480510
[TBL] [Abstract][Full Text] [Related]
31. Neuroprotective activity of selenium nanoparticles against the effect of amino acid enantiomers in Alzheimer's disease.
Vicente-Zurdo D; Rodríguez-Blázquez S; Gómez-Mejía E; Rosales-Conrado N; León-González ME; Madrid Y
Anal Bioanal Chem; 2022 Nov; 414(26):7573-7584. PubMed ID: 35982253
[TBL] [Abstract][Full Text] [Related]
32. Insight into the inhibition effect of acidulated serum albumin on amyloid β-protein fibrillogenesis and cytotoxicity.
Xie B; Li X; Dong XY; Sun Y
Langmuir; 2014 Aug; 30(32):9789-96. PubMed ID: 25083748
[TBL] [Abstract][Full Text] [Related]
33. Surface functionalization of methotrexate-loaded chitosan nanoparticles with hyaluronic acid/human serum albumin: Comparative characterization and in vitro cytotoxicity.
Hashad RA; Ishak RA; Geneidi AS; Mansour S
Int J Pharm; 2017 Apr; 522(1-2):128-136. PubMed ID: 28279742
[TBL] [Abstract][Full Text] [Related]
34. Study on the efficiency and interaction mechanism of a decapeptide inhibitor of β-amyloid aggregation.
Liu J; Wang W; Zhang Q; Zhang S; Yuan Z
Biomacromolecules; 2014 Mar; 15(3):931-9. PubMed ID: 24443821
[TBL] [Abstract][Full Text] [Related]
35. Hyaluronic acid-coated chitosan nanoparticles induce ROS-mediated tumor cell apoptosis and enhance antitumor efficiency by targeted drug delivery via CD44.
Wang T; Hou J; Su C; Zhao L; Shi Y
J Nanobiotechnology; 2017 Jan; 15(1):7. PubMed ID: 28068992
[TBL] [Abstract][Full Text] [Related]
36. Interactions of amyloid Aβ(1-42) peptide with self-assembled peptide nanospheres.
Smoak EM; Dabakis MP; Henricus MM; Tamayev R; Banerjee IA
J Pept Sci; 2011 Jan; 17(1):14-23. PubMed ID: 20814889
[TBL] [Abstract][Full Text] [Related]
37. Obstacles to translating the promise of nanoparticles into viable amyloid disease therapeutics.
van der Munnik NP; Moss MA; Uline MJ
Phys Biol; 2019 Feb; 16(2):021002. PubMed ID: 30620933
[TBL] [Abstract][Full Text] [Related]
38. Facile design of autogenous stimuli-responsive chitosan/hyaluronic acid nanoparticles for efficient small molecules to protein delivery.
Sabourian P; Ji J; Lotocki V; Moquin A; Hanna R; Frounchi M; Maysinger D; Kakkar A
J Mater Chem B; 2020 Aug; 8(32):7275-7287. PubMed ID: 32638822
[TBL] [Abstract][Full Text] [Related]
39. Influence of gold nanoparticle surface chemistry and diameter upon Alzheimer's disease amyloid-β protein aggregation.
Moore KA; Pate KM; Soto-Ortega DD; Lohse S; van der Munnik N; Lim M; Jackson KS; Lyles VD; Jones L; Glassgow N; Napumecheno VM; Mobley S; Uline MJ; Mahtab R; Murphy CJ; Moss MA
J Biol Eng; 2017; 11():5. PubMed ID: 28191036
[TBL] [Abstract][Full Text] [Related]
40. Chitosan Oligosaccharides Inhibit/Disaggregate Fibrils and Attenuate Amyloid β-Mediated Neurotoxicity.
Dai X; Hou W; Sun Y; Gao Z; Zhu S; Jiang Z
Int J Mol Sci; 2015 May; 16(5):10526-36. PubMed ID: 26006224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
